Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.
Saved in:
| Title: | Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling. |
|---|---|
| Authors: | Dupuy M; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Gueguinou M; N2COx UMR 1069, University of Tours,INSERM, Tours, France., Postec A; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Brion R; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; CHU Nantes, Nantes, France., Tesfaye R; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Mullard M; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Regnier L; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Amiaud J; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Hubsch C; UMR CNRS 7021, Translational, Transversal and Therapeutic Oncology (OnKO-3T) Team, University of Strasbourg, Illkirch, France., Potier-Cartereau M; N2COx UMR 1069, University of Tours,INSERM, Tours, France., Chantôme A; N2COx UMR 1069, University of Tours,INSERM, Tours, France., Brounais-Le Royer B; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Baud'huin M; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; CHU Nantes, Nantes, France., Georges S; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Lamoureux F; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Ory B; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Entz-Werlé N; UMR CNRS 7021, Translational, Transversal and Therapeutic Oncology (OnKO-3T) Team, University of Strasbourg, Illkirch, France.; Pediatric Onco-Hematology Unit, University Hospitals of Strasbourg, Strasbourg, France., Delattre O; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center,Institut Curie, Paris, France., Rédini F; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France., Vandier C; N2COx UMR 1069, University of Tours,INSERM, Tours, France., Verrecchia F; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France. franck.verrecchia@univ-nantes.fr. |
| Source: | Oncogene [Oncogene] 2025 Jan; Vol. 44 (2), pp. 79-91. Date of Electronic Publication: 2024 Nov 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39487324 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dupuy+M%22">Dupuy M</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Gueguinou+M%22">Gueguinou M</searchLink>; N2COx UMR 1069, University of Tours,INSERM, Tours, France.<br /><searchLink fieldCode="AU" term="%22Postec+A%22">Postec A</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Brion+R%22">Brion R</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; CHU Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Tesfaye+R%22">Tesfaye R</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Mullard+M%22">Mullard M</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Regnier+L%22">Regnier L</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Amiaud+J%22">Amiaud J</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Hubsch+C%22">Hubsch C</searchLink>; UMR CNRS 7021, Translational, Transversal and Therapeutic Oncology (OnKO-3T) Team, University of Strasbourg, Illkirch, France.<br /><searchLink fieldCode="AU" term="%22Potier-Cartereau+M%22">Potier-Cartereau M</searchLink>; N2COx UMR 1069, University of Tours,INSERM, Tours, France.<br /><searchLink fieldCode="AU" term="%22Chantôme+A%22">Chantôme A</searchLink>; N2COx UMR 1069, University of Tours,INSERM, Tours, France.<br /><searchLink fieldCode="AU" term="%22Brounais-Le+Royer+B%22">Brounais-Le Royer B</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Baud'huin+M%22">Baud'huin M</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.; CHU Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Georges+S%22">Georges S</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Lamoureux+F%22">Lamoureux F</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Ory+B%22">Ory B</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Entz-Werlé+N%22">Entz-Werlé N</searchLink>; UMR CNRS 7021, Translational, Transversal and Therapeutic Oncology (OnKO-3T) Team, University of Strasbourg, Illkirch, France.; Pediatric Onco-Hematology Unit, University Hospitals of Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Delattre+O%22">Delattre O</searchLink>; INSERM U830, Diversity and Plasticity of Childhood Tumors Lab, PSL Research University, SIREDO Oncology Center,Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Rédini+F%22">Rédini F</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Vandier+C%22">Vandier C</searchLink>; N2COx UMR 1069, University of Tours,INSERM, Tours, France.<br /><searchLink fieldCode="AU" term="%22Verrecchia+F%22">Verrecchia F</searchLink>; Nantes Université, INSERM UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France. franck.verrecchia@univ-nantes.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2025 Jan; Vol. 44 (2), pp. 79-91. <i>Date of Electronic Publication: </i>2024 Nov 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39487324 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41388-024-03199-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 79 Titles: – TitleFull: Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dupuy M – PersonEntity: Name: NameFull: Gueguinou M – PersonEntity: Name: NameFull: Postec A – PersonEntity: Name: NameFull: Brion R – PersonEntity: Name: NameFull: Tesfaye R – PersonEntity: Name: NameFull: Mullard M – PersonEntity: Name: NameFull: Regnier L – PersonEntity: Name: NameFull: Amiaud J – PersonEntity: Name: NameFull: Hubsch C – PersonEntity: Name: NameFull: Potier-Cartereau M – PersonEntity: Name: NameFull: Chantôme A – PersonEntity: Name: NameFull: Brounais-Le Royer B – PersonEntity: Name: NameFull: Baud'huin M – PersonEntity: Name: NameFull: Georges S – PersonEntity: Name: NameFull: Lamoureux F – PersonEntity: Name: NameFull: Ory B – PersonEntity: Name: NameFull: Entz-Werlé N – PersonEntity: Name: NameFull: Delattre O – PersonEntity: Name: NameFull: Rédini F – PersonEntity: Name: NameFull: Vandier C – PersonEntity: Name: NameFull: Verrecchia F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1476-5594 Numbering: – Type: volume Value: 44 – Type: issue Value: 2 Titles: – TitleFull: Oncogene Type: main |
| ResultId | 1 |